Você procurou por: metformina (Croata - Inglês)

kombinacija pioglitazona i metformina
pioglitazone and metformin combination

dio metformina ulazi u eritrocite.
metformin partitions into erythrocytes.

istodobna primjena dapagliflozina i metformina
coadministration of dapagliflozin and metformin

dolutegravir je povećao koncentracije metformina.
dolutegravir increased metformin concentrations.

vareniklin nije utjecao na farmakokinetiku metformina.
varenicline did not affect the pharmacokinetics of metformin.

nuspojave zabilježene pri uzimanju samo metformina:
side effects seen when taking metformin alone:

najdjelotvornija metoda uklanjanjanja metformina je hemodijaliza.
the most effective method of removing metformin is haemodialysis.

hrana smanjuje i neznatno odgađa apsorpciju metformina.
food decreases the extent and slightly delays the absorption of metformin.

ispitivanja metformina na životinjama nisu pokazala reproduktivnu toksičnost.
for metformin, studies in animals have not shown reproductive toxicity.

hrana neznatno odgađa i smanjuje opseg apsorpcije metformina.
food slightly delays and decreases the extent of the absorption of metformin.

za bolesnike koji prelaze s odvojenih tableta empagliflozina i metformina
for patients switching from separate tablets of empagliflozin and metformin

alogliptin kao dodatna terapija inzulinu (s ili bez metformina)
alogliptin as add-on therapy to insulin (with or without metformin)

maksimalna doza iznosi 5 mg linagliptina i 2 000 mg metformina dnevno.
the maximum dose is 5 mg of linagliptin and 2,000 mg of metformin per day.

kombinacija saksagliptina i metformina ispitana je u tromjesečnom ispitivanju na psima.
a 3-month dog study was conducted with the combination of saxagliptin and metformin.

ako je potrebno, na lijek competact može se izravno prijeći s metformina.
it is possible to change to competact directly from metformin if appropriate.

nakon peroralne primjene apsorpcija metformina je nepotpuna i odvija se do zasićenja.
after oral administration, metformin absorption is saturable and incomplete.

hipoglikemija nije utvrđena kao nuspojava linagliptina, metformina ili kombinacije linagliptin plus metformin.
hypoglycaemia is not identified as adverse reaction for linagliptin, metformin, or linagliptin plus metformin.

nuspojave koje se javljaju uz uzimanje metformina samostalno, koje nisu opisane za kanagliflozin:
side effects when taking metformin alone that were not described for canagliflozin:

istodobna primjena aliskirena nije imala značajan utjecaj na farmakokinetiku atorvastatina, metformina ili amlodipina.
co- administration of aliskiren had no significant impact on atorvastatin, metformin or amlodipine pharmacokinetics.

istraživanja metformina na životinjama nisu ukazala na reproduktivnu toksičnost (vidjeti dio 5.3).
for metformin, studies in animals have not shown reproductive toxicity (see section 5.3).